Form D · Biotechnology
ALZpath, Inc.
Carlsbad, CA · CIK 0002145244
Offering snapshot reported Jul 21, 2026 · SEC filing
- Reported sold
- $8.41M Offering amount: $10.4M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 14, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 21, 2026 | Initial | $8,411,219 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $125K
- Form D file number
- 021-591637
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| AEG Capital, LLC | 168097 |
Source: Form D, filed Jul 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Banville | Executive, Promoter |
| John Courtney | Director |
| Samantha Budd Haeberlein | Director |
| John Hensing | Director |
| Harry Johns | Director |
| Irit Rappley | Director |
| Jerre Stead | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2292 Farday Avenue
Carlsbad, CA, 92008
Phone: 617-645-2294
Carlsbad, CA, 92008
Phone: 617-645-2294